참여교수

SNU BIOMEDICAL SCIENCE PROGRAM

Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase.
조주연
CTS-Clinical and Translational Science, , 2021.12, LINK
Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects
조주연
CTS-Clinical and Translational Science, 14(5), 2021.09, LINK
Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.
조주연
Scientific Reports, 11(1), 2021.09, LINK
Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids
조주연
DIABETES RESEARCH AND CLINICAL PRACTICE, 178, 2021.08, LINK
Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD
조주연
Frontiers in Medicine, 8, 2021.05, LINK
Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men
조주연
Frontiers in Cellular and Infection Microbiology, 11, 2021.05, LINK
Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects
조주연
Drug Design Development and Therapy, 15, 2021.04, LINK
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators
조주연
Pharmacogenetics and Genomics, 31(3), 2021.04, LINK
Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects
조주연
CLINICAL THERAPEUTICS, 43(3), 2021.03, LINK
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects
조주연
Drug Metabolism and Pharmacokinetics, 36, 2021.02, LINK